On January 17, 2021, two vaccines were approved by ANVISA for emergency use to help combat COVID-19: Coronavac and Covishield/Oxford. The first vaccine is composed of inactivated (killed) viruses, was produced the Chinese company Sinovac in Brazil, will be Butantã Institute (São Paulo). second an adenovirus non-replicating viral vector pharmaceutical Serum India partnership with AstraZeneca/Oxf...